Stocksigma LogoStocksigma Logo

Godavari Drugs Q2 Results: Operational Revenue Expands YoY

Godavari Drugs reported Q2 revenue from operations of ₹28.23 crore, growing 5.9% YoY from ₹26.65 crore and marginally up QoQ from ₹27.96 crore

Godavari Drugs Q2 Results: Operational Revenue Expands YoY

Godavari Drugs Ltd · Financial Result · 11 Nov 2026, 10:51 pm

Godavari Drugs Q2 Results: Operational Revenue Expands YoY Godavari Drugs reported Q2 revenue from operations of ₹28.23 crore, growing 5.9% YoY from ₹26.65 crore and marginally up QoQ from ₹27.96 crore. Net profit declined to ₹0.96 crore versus ₹1.00 crore in Q2 of the previous fiscal and ₹1.11 crore in Q1. Diluted EPS stood at ₹0.90 for the quarter ended 30th Sep'26. H1 revenue rose 11.3% YoY to ₹56.18 crore with net profit at ₹2.07 crore. Capital expenditure allocation from preferential issue proceeds progressed without deviations.

Original exchange filing (PDF)

More announcements from Godavari Drugs Ltd

All Godavari Drugs Ltd announcements